Drug may help bone marrow failure patients recover faster after transplant
NCT ID NCT05466201
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called eltrombopag in 118 people with bone marrow failure who had a stem cell transplant. The goal was to see if the drug could help their platelet levels recover faster after the transplant. Platelets are blood cells that help stop bleeding, and slow recovery is a common problem after transplant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE MARROW FAILURE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215006, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A bedtime kit for the hospital: can ear plugs and a lightbox help young transplant patients sleep?
- New hope for kids with sickle cell: stem cell transplant from mismatched blood type donors
- New pill aims to keep leukemia away after transplant
- New drug cocktail aims to tame deadly transplant complication
- Can a smartphone app boost sexual health after a stem cell transplant?
- Gut check: Antibiotics' hidden impact on stem cell transplants revealed